We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Drop Assay Designed for Monitoring Antimalarial Drug Resistance

By LabMedica International staff writers
Posted on 24 Jun 2019
A new method for analyzing DNA directly in a drop of blood was designed for monitoring development of resistance to antimalarial drugs.

Monitoring of antimalarial resistance in the Plasmodium falciparum parasite is important to prevent further spread of the disease, but the available options for assessing resistance are not usually applicable to field conditions. More...
Although molecular detection is perhaps the most efficient method, it is also the most complex because it requires DNA extraction and PCR instrumentation.

To develop an approach more suited for use outside the traditional laboratory, investigators at Vanderbilt University (Nashville, TN, USA) designed new probes, which, when used in combination with an inhibitor-tolerant Taq polymerase, enabled single-nucleotide polymorphism genotyping directly from whole blood. The Taq polymerase enzyme is a thermostable DNA polymerase I named after the thermophilic bacterium Thermus aquaticus from which it was originally isolated. It is frequently used in the polymerase chain reaction (PCR), a method for greatly amplifying the quantity of short segments of DNA.

The new probes featured two strategic design elements: locked nucleic acids to enhance specificity and the reporter dyes Cy5 and TEX615, which have less optical overlap with the blood absorbance spectra than other commonly used dyes. Probe performance was validated on a traditional laboratory-based instrument and then further tested on a field-deployable Adaptive PCR instrument.

Adaptive PCR is a previously described real-time PCR platform that used left-handed DNA (L-DNA) additives to monitor the reaction for more reliable point-of-care performance. This method was fundamentally simpler and more robust than traditional PCR. It functions by dynamically controlling thermal cycling through direct monitoring of the two key hybridization events - primer annealing and product melting - during the reaction.

Results obtained during the study revealed that the probes could discriminate between wild-type P. falciparum and a chloroquine-resistant mutant in the presence of 2% blood. This strategy greatly simplified single-nucleotide polymorphism detection and provided a more accessible alternative for antimalarial resistance surveillance in the field.

"To mitigate the inhibition by blood components, we redesigned the molecular tools used for DNA analysis. We utilized reporter dyes that are more optically compatible with blood, which were combined with a specific type of DNA subunit to accurately pinpoint mutations. The end result is an assay in which blood is directly added to a reaction tube to detect mutations associated with antimalarial drug resistance," said senior author Dr. Frederick R. Haselton, professor of biomedical engineering and chemistry at Vanderbilt University.

The antimalarial resistance study was published in the June 13, 2019, online edition of the Journal of Molecular Diagnostics.

Related Links:
Vanderbilt University


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.